Mastering the Pre-IND Meeting: Your Roadmap to Successful Drug Development
Launching a new drug product in the market is a complex and highly regulated process that demands careful planning and adherence to Regulatory requirements. During the drug development journey, conducting a pre-Investigational New Drug (IND) meeting is a crucial opportunity for life sciences companies to engage with Regulatory Authorities and obtain guidance, feedback, and agreement on their drug development plans.